missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ EphB3 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA582337
This item is not returnable.
View return policy
Description
Immunogen sequence: GDGEWMVPVG ACTCATGHEP AAKESQCRPC PPGSYKAKQG EGPCLPCPPN SRTTSPAASI CTCHNNFYRA DSDSADSACT TVPSPPRGVI SNVNETSLIL EWSEPRDLGG RDDLLYNVIC KKCHGAGGAS ACSRCDDNVE FVP Highest antigen sequence indentity to the following orthologs: Mouse - 95%, Rat - 92%.
EPHB3 is a receptor tyrosine kinase that belongs to the ephrin receptor family. Members of the Eph family of kinases play important roles in diverse biological processes including nervous system development, angiogenesis and neural synapsis formation and maturation. The ephrin ligands and Eph receptors display reciprocal expression in vivo. Developing and adult neural tissue express nearly all of the Eph receptors and ephrin ligands. Ephs and ephrins play a significant role in angiogenesis.
Specifications
| EphB3 | |
| Polyclonal | |
| Unconjugated | |
| EPHB3 | |
| AW456895; Cek10; Developmental kinase 5; EK2; Embryonic kinase 2; EPH receptor B3; EPHB3; EPH-like kinase 2; EPH-like tyrosine kinase 2; EPH-like tyrosine kinase-2; Ephrin type-B receptor 3; Etk2; HEK2; human embryo kinase 2; Mdk5; mDK-5; Sek4; TYRO6; tyrosine-protein kinase receptor SEK-4; Tyrosine-protein kinase TYRO6 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 2049 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.1 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| P54753 | |
| EPHB3 | |
| Recombinant protein corresponding to Human EPHB3. Recombinant protein control fragment (Product #RP-89818). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction